info@lightchainbio.com
+41 22 552 72 00
Find us
Please enter the email address associated with your User account. Your username will be emailed to the email address on file.
Written by Mei Liang Belhumeur on Thursday, 02 May 2024. Posted in News
First-in-human trial of a CEACAM5xCD3 bispecific κλ body for solid cancer
Read more